PROGRAMME

Kindly note that the programme will still be subject to changes.

 

Thursday, October 22, 2026

Room 1

08:00-09:00
AI in cardiovascular imaging: The time is now?! (All Levels)
Moderators: C. Loewe, Vienna/AT | J. Weir McCall, Cambridge/UK
Strengths and challenges of AI in imaging
K. Hanneman, Toronto/CA
AI in cardiac CT: Current role, future outlook
K. Nikolaou, Tuebingen/DE
AI in cardiac MRI: Current role, future outlook
A. Swift, Sheffield/UK
Q&A

09:00-09:05 Break

09:05-10:05
ESCR meets NASCI: Aorta imaging and beyond (All Levels)
Moderators: R. Budde, Rotterdam/NL | K. Hanneman, Toronto/CA
ESCR aortic imaging practice recommendations
N. Galea, Rome/IT
Non-invasive imaging in peripheral arterial occlusive disease
P. Rajiah, Rochester/US
How does PCCT change vascular imaging?
K. Hanneman, Toronto/CA
Q&A

10:05-10:20 Pitch Session: From innovation to impact – Part I
Moderator: R. Vliegenthart, Groningen/NL

10:20-10:50 Break

10:50-11:00
Opening Ceremony
Moderator: M. Francone, Rome/IT | R. Salgado, Antwerp/BE
Introduction & Welcome to Rotterdam
R. Vliegenthart, Rotterdam/NL

11:00-12:00
Opening Session: Connect to Impact
Moderators: M. Francone, Rome/IT | R. Salgado, Antwerp/BE

ESCR: Connecting cardiovascular radiologists
M. Francone, Rome/IT
The EU Safe Hearts plan: where does imaging fit in?
R. Salgado, Antwerp/BE
From diagnosis to prevention in Europe
R. Vliegenthart, Groningen/NL

12:00-12:10 Break
12:10-12:55 Industry Symposium
12:55-13:20 Break

13:20-14:35
Update on ischemia imaging (All Levels)
Moderators: J. Habets, Nieuwegein/NL | P. van der Harst, Groningen/NL
Guidelines on ischemia imaging in CAD management
R. Nijveldt, Nijmegen/NL
Current role of FFR-CT and CT perfusion
J. Weir-McCall, London/UK
Update on myocardial perfusion MRI
G. Bastarrika, Pamplona/ES
MRI to assess coronary vascular (dys)function
M. Friedrich, Montreal/CA
Q&A

14:35-14:40 Break
14:40-15:05 Industry Slot
15:05-15:35 Break

15:35-17:05
ESCR meets other imaging societies (All Levels)
Moderators: M. Francone, Rome/IT | R. Vliegenthart, Groningen/NL
Radiographers: role in cardiac imaging
P. Cornacchione, Rome/IT (EFRS)
Towards high-value, sustainable cardiac imaging
K. Hanneman, Toronto/CA (RSNA)
Updates on cardiac CT/MRI in European guidelines
R. Nijveldt, Nijmegen/NL (EACVI)
MRI trials with impact on clinical routine
V. Ferreira, Oxford/UK (SCMR)
CT trials with clinical diagnostic impact
J. Weir-McCall, London/UK (SCCT)
Q&A

17:10-18:10
Crack the Case: An Interactive Cardiovascular Imaging Quiz
M. Halfmann, Mainz/DE | G. Tremamunno, Rome/IT | E. Zsarnoczay, Budapest/HU

Room 2

08:00-09:00
Scientific Session 1: Cardiac MR imaging – Tissue characterization at it’s best
Moderators: C. Glessgen, Geneva/CH | J. Luetkens, Bonn/DE
Agreement between cardiac CT and CMR for left ventricular morpho‑functional assessment and myocardial strain in STEMI: a sub‑study of the CT‑STEMI trial
S. Moballeghi, Turin/IT
MRI-derived wall thickness heterogeneity in hypertrophic cardiomyopathy and in carriers of sarcomeric gene mutations
M. Alberti, Pisa/IT
Non-Contrast CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis Using Myocardial Strain and Left Ventricular Remodeling Index
Z. Magomedova, Moscow/RU
Liver T1 in Cardiac MRI: A Novel Predictor of Heart Failure and MACE
A. Peters, Bern/CH
Native T1 and myocardial strain in transfusion-dependent thalassemia with preserved LVEF and normal myocardial T2* values.
N. Pegoraro, Ferrara/IT
Improved detection of RV fibrosis using dark-blood LGE CMR and impact on arrhythmogenic right ventricular cardiomyopathy diagnosis
R. Holtackers, Maastricht/NL
Shape analysis study of the left ventricle in adult patients who underwent the arterial switch operation using statistical shape modelling
T. Hanna, Bristol/UK

 

09:00-09:05 Break

09:05-10:05
Scientific Session 2: Cardiac CT imaging I – Pushing the boundaries 
Moderators: M. Halfmann, Mainz/DE | G. Muscogiuri, Bergamo/IT
Illuminating the unseen: detecting myocardial fibrosis with photon-counting detector CT
M.J. Lemmens, Maastricht/NL
Non-invasive imaging of cardiac allograft vasculopathy and myo-cardial composition in heart transplantation. A prospective ex-ploratory study using cardiac Photon-Counting Computed Tomography (PCCT)
D. Beitzke, Vienna/AT
Improving Coronary Plaque Classification with Ultra–High-Resolution Photon-Counting CT Compared with Standard-Resolution Imaging: Validation against Optical Coherence Tomography and Histology
Y. Wang, Beijing/CN
Impact of slice thickness in photon-counting CT on the detectability of coronary artery calcium
M. Papavasileiou, Groningen/NL
Relative Electron Density (RED) from Constrained Multienergy Material Decomposition Outperforms HU and Zeff for Identifying Lipid-Rich Necrotic Core from Fibrous Plaque in Dual-Energy CT: A Phantom Study
S. Newlander, La Jolla/US
Point-by-Point Co-Registration of Photon-Counting CT and Electro-Anatomical Mapping for Structural Substrate Characterisation in Ventricular Tachycardia
A. Colombo, Milan/IT
Ultra-High-Resolution Photon-Counting CT for the assessment of hypoattenuated leaflet thickening after Transcatheter Aortic Valce Replacement
A. Kilburg, Mainz/DE

10:05-13:20 Break

13:20-14:35
Imaging in cardio-oncology: Staying on top of treatment strategies (Advanced)
Moderators: A. Buz Yasar, Bolu/TR | B. Wintersperger, Toronto/CA
Imaging cardiac effects of non-immunotherapy systemic cancer therapies
A. Jacquier, Marseilles/FR
Cardiac MRI in cancer immunotherapy: Are biopsies outdated?
J. Luetkens, Bonn/DE
Imaging of radiation‐induced coronary artery disease
E. Mousseaux, Paris/FR
Role of nuclear imaging in cardio-oncology
A. Weustink, Rotterdam/NL
Q&A

14:35-15:35 Break

15:35-17:05
Basics of cardiac CT and MRI: Technical details explained (Basic)
Moderators: R. Takx, Amsterdam/NL | E. Zsarnoczay, Budapest/HU
MRI for tissue characterization
M. Hrabak Paar, Zagreb/HR
Contrast media injection protocols for EID-CT and PC-CT
C. Mihl, Maastricht/NL
Stress MRI perfusion – Pearls and pitfalls
S. Ley, Munich/DE
Stress perfusion CT – Static and dynamic
T. Emrich, Mainz/DE
4D flow MRI – When and how
J. Westenberg, Leiden/NL
Q&A

Friday, October 23, 2026

Room 1

08:00-09:00
Non-invasive imaging in ACS: The radiologist on the frontline (All Levels)
Moderators: J. Carvalho, Porto/PT
CT at initial presentation in the ED: Can we exclude CAD?
R. Salgado, Antwerp/BE
MRI: Is it MINOCA/Takotsubo/myocarditis…?
M. Pirnat, Maribor/SI
Imaging in OHCA: How and why?
B.K. Velthuis, Utrecht/NL
Q&A
 
09:00-09:05 Break
 
09:05-10:05
ESCR meets ESTI: Connecting chest CT and cardiovascular pathology (All Levels)
Moderators: K. Nikolaou, Tuebingen/DE | A. P. Parkar, Bergen/NO
Updates on lung cancer screening
M. Silva, Parma/IT
Coronary calcium evaluation on chest CT?
A. P. Parkar, Bergen/NO
ESTI/ESCR consensus on imaging pulmonary hypertension
K-F. Kreitner, Mainz/DE
Q&A
 
10:05-10:35 Break
 
10:35-12:05
Imaging of cardiomyopathies (All Levels)
Moderators: A. Ezponda, Pamplona/ES | M. Gutberlet, Leipzig/DE
Guidelines: Phenotypic approach to cardiomyopathies
J. Shambrook, Southampton/UK
Risk stratification and follow-up in cardiomyopathies
B. Wintersperger, Toronto/CA
Pediatric cardiomyopathies
P. Agarwal, Minneapolis/US
Diving into hypertrophic phenotypes
C. Gkizas, Lille/FR
Arrhythmogenic cardiomyopathy: A moving target
L. Natale, Rome/IT
Q&A
 
112:05-12:15 Break
12:15-13:00 Industry Symposium
13:00-13:25 Break
 
13:20-13:50 Honorary Session: Impact of cardiovascular radiology 
Moderators: M. Francone, Rome/IT | R. Salgado, Antwerp/BE
13:50-13:55 Awarding Ceremony
Moderators: M. Francone, Rome/IT | R. Salgado, Antwerp/BE
 
13:55-14:10 Pitch Session: From innovation to impact – Part II
Moderators: R. Vliegenthart, Groningen/NL
 
14:15-15:30
Coronary CTA: Impact beyond stenosis (All Levels)
Moderators: F. Secchi, Milan/IT | G. Staskiewicz, Lublin/PL
Plaque quantification: Why and how?
M. Dewey, Cambridge/UK
Stent assessment: Current status
H. Alkadhi, Zurich/CH
Cardiac fat measures: Ready for implementation?
P. Maurovich-Horvat, Budapest/HU
How does PCCT change coronary CTA beyond stenosis?
S. Boccalini, Lyon/FR
Q&A
 
15:30-15:35 Break
15:35-16:00 Industry Slot
16:00-16:30 Break
 
16:30-18:00
Towards optimal MRI protocols and workflow (All Levels)
Moderators: V. Groudeva, Sofia/BG | L. Natale, Rome/IT
Abbreviated protocols: Do we need all sequences in all cardiac MRIs?
R. Salgado, Antwerp/BE
Free breathing MRI – Uncooperative patients/young children
G. Muscogiuri, Bergamo/IT
Towards non-contrast cardiac MRI
M. Friedrich, Montreal/CA
Imaging in presence of pacemaker/ICD
J. Bremerich, Basel/CH
Rapid, undersampled MRI
A. Chiribiri, London/UK
Q&A

Room 2

08:00-09:00
Scientific Session 3: Cardiac CT imaging II – Pushing the boundaries
Moderators: H. Alkadhi, Zurich/CH | M. Tregubova, Kyiv/UA
Prognostic value of quantitative Photon-Counting CT biomarkers in Cardiac Allograft Vasculopathy after Heart Transplantation
C. Gkizas, Lille/FR
Role of Coronary CT Angiography (CCTA) in the Preoperative Assessment of Coronary Artery Disease (CAD) in Patients with Aortic Infective Endocarditis (IE) Undergoing Valve Surgery
G. Rovere, Rome/IT
Coronary Artery Plaque Composition and Structure: A Plaque-to-Plaque Comparison Between Energy-Integrating Detector CT and Photon-Counting CT
W-J. Lee, Taipei City/TW
CT-Derived Artificial Intelligence Improves Detection of Pulmonary Hypertension Compared with Echocardiographic Risk Stratification
M. Sharkey, Sheffield/UK
Photon-Counting Detector Cardiac CT for Hemodynamic Assessment of Valve Dysfunction after Transcatheter Aortic Valve Replacement
S. Hyska, Charleston/US
Prognostic Value of a Coronary CT Angiography-based Fractional Flow Reserve Deep Learning Model for Predicting Cardiovascular Events: Comparison with Invasive FFR and iFR
L. Bijnens, Leuven/BE
Cardiac CT in the Acute Stroke Protocol: Left Atrial Enhancement Patterns and Embolic Source Detection in Anticoagulated Patients with Atrial Fibrillation
E. Baettig, Barcelona/ES

09:00-09:05 Break

09:05-10:05
Poster Session
Moderators: G. Francese, Rouen/FR | B. Wintersperger, Toronto/CA
Cardiac Magnetic Resonance Features of SLC25A4‑Related Mitochondrial Cardiomyopathy
L. Musayeva, Baku/AZ
Noonan syndrome: Evaluation of cardiovascular abnormalities using CT and MRI
E. Jellin, Zagreb/HR
Role of Cross-Sectional Imaging in Transcatheter Repair of PAPVR with Sinus Venosus Defect
H. Sudarsan, Liverpool/UK
More than meets the eye: distinguishing true hypertrophy from phenotypic mimics
A. Boulmpou, Nijmegen/NL
When Hounsfield Units Lie: Chylopericardium – A rare entity
F. Cano Mateos, Donostia-San Sebastián/ES
Same Scan, Different Answers: Where You Measure Matters in Congenital Heart Disease MRI
S. Priya, Madison/US
High Attenuation Artifact Stress Testing Reveals Differences in Robustness of Relative Electron Density and Effective Atomic Number in Spectral CT
G. Wesbey, La Jolla/US
Comparison of standard and experimental T2 Mapping sequences for myocardial tissue characterization in cardiac MRI
F. Edelmann, Tuebingen/DE
Quantitative Standardization of 3.0T Cardiac T1 Mapping Using a Phantom-Based Correction Model in a Multi-Vendor, Multi-Scanner Environment
J.M. Kim, Seongnam/KR
Pericoronary Adipose Tissue Changes in Rapid Cardiac Allograft Vasculopathy Assessed by CCTA
M. Boussoussou, Budapest/HU
Genotype–phenotype interplay in hypertrophic cardiomyopathy: the added value of cardiac magnetic resonance (cmr)
L. M. De Sanctis, Rome/IT
Pericoronary Adipose Tissue on CCTA for Prediction of MACE: Systematic Review and Meta-Analysis
D. Verna, Turin/IT

10:05-10:35 Break

10:35-12:05
Imaging for cardiovascular intervention planning (All Levels)
Moderators: M. Hrabak Paar, Zagreb/HR | M. Pop, Targu-Mures/RO
Workup for mitral valve/LAA interventions
A. Esposito, Milan/IT
MRI guided interventions: Realtime imaging fusion
M. Guglielmo, Utrecht/NL
Workup for ablation of arrhythmias
J. E. Lee, Seoul/KR (KOSCI)
Workup for TAVI
C. Celeng, Utrecht/NL
CCTA/CT-FFR to guide coronary intervention planning?
F. Catapano, Milan/IT
Q&A

12:05-14:15 Break

14:15-15:30
Connecting disciplines: The radiologist connected to… (All Levels)
Moderators: J. Bremerich, Bern/CH | N. Kelekis, Athens/GR
The pulmonary oncologist (cardiac invading tumors)
G. Tremamunno, Rome/IT
The cardiogeneticist (genetic CMP)
A. Hirsch, Rotterdam/NL
The infectious disease specialist (inflammation/endocarditis)
J. Broncano, Cordoba/ES
The neurologist (cardioembolic stroke)
B. Velthuis, Utrecht/NL
Q&A

15:30-16:30 Break

16:30-18:00
How to read congenital heart disease imaging: Case-based (Advanced)
Moderators: M. Pirnat, Maribor/SI | T. Yalynska, Kyiv/UA
Grown ups with (incidental) CHD
A. Spijkerboer, Amsterdam/NL
Tetralogy of Fallot
A. Secinaro, Rome/IT
Shunts: ASD, VSD, PAPVR…
F. Zuccarino, Barcelona/ES
Transposition of the great arteries
T. Semple, London/UK
Q&A

Saturday, October 24, 2026

Room 1

08:30-09:30
Updates on valvular imaging (Advanced)
Moderators: M. Ishchenko, Kyiv/UA | R. Manka, Zurich/CH
Guidelines: Role of CT/MRI in valvular heart disease
A. Hirsch, Rotterdam/NL
Updates in echocardiography for valvular imaging
K. Sienkiewicz, Gdansk/PL
Valvular imaging: 4D-flow MRI and beyond
A. Azarine, Paris/FR
Q&A
 
09:30-09:35 Break
 
09:35-10:35
Towards optimal CT protocols and workflow (All Levels)
Moderators: C. Mihl, Maastricht/NL | N. Almeida Aróstegui, Madrid/ES
How do we reduce radiation dose without loss of quality?
M. Williams, Edinburgh/UK
Spectral CT imaging: When is it helpful?
F. Pontana, Lille/FR
Standardization of CT reporting: How to – role for AI?
M. Van Assen, Atlanta/US
Q&A
 
10:35-11:05 Break
 
11:05-12:35
Imaging of post-procedural complications: Case-based (All Levels)
Moderators: T. Emrich, Mainz/DE | B. Wintersperger, Toronto/CA

Imaging after treatment of thoracic aorta
C. Loewe, Vienna/AT
Imaging after cardiac transplantation/LVAD
R. Budde, Rotterdam/NL
Imaging after arrhythmia ablation
M. Eberhard, Zurich/CH
Post-valvular intervention imaging
N. Fink, Munich/DE
Q&A
 
12:35-12_45 Break
12:45-13:30 Industry Symposium
13:30-13:55 Break
 
13:55-15:25
MRI functional and tissue evaluation (All Levels)
Moderators: T. Mittal, London/UK | F. Pontana, Lille/FR
Role of MRI in heart failure guidelines
M. Francone, Milan/IT
MRI tissue characteristics in ischemic cardiomyopathy
A. Kallifatidis, Thessaloniki/GR
MRI tissue characteristics in non-ischemic cardiomyopathies
A. Palmisano, Milan/IT
MRI: Role in myocarditis
M. Gutberlet, Leipzig/DE
Strain MRI: When, how, and why?
R. Manka, Zurich/CH
Q&A

15:25-15:30 Break

15:30-15:35
Closing Ceremony
M. Francone, Rome/IT | R. Salgado, Antwerp/BE | R. Vliegenthart, Groningen/NL

Room 2

08:30-09:30
How to identify CT/MRI artifacts – and prevent them (Basic)
Moderators: G. Tremamunno, Rome/IT | M. Vecsey-Nagy, Charleston/US
MRI: Motion artifacts
N. Lama, Athens/GR
MRI: Signal artifacts
R. Holtackers, Maastricht/NL
CT: Motion, trigger, stent and device artifacts
M. Dijkshoorn, Rotterdam/NL
Q&A
 
09:30-09:35 Break
 
09:35-10:35
Acute vascular pathology (Basic)
Moderators: S. Boccalini, Lyon/FR | R-A. Licu, Targu-Mures/RO
Acute pulmonary embolism: How to scan and evaluate
B. Ghaye, Brussels/BE
Pearls in imaging for diagnosis of acute aortic syndrome
D. Suchá, Utrecht/NL
Triple rule out CT: When to consider?
S.M. Ko, Wonju/KR
Q&A
 
10:35-11:05 Break
 
11:05-12:35
ESCR meets ASCI: The heart and vessels in systemic disease
Moderators: M. Francone, Rome/IT | C. Chan, Hong Kong/CN
Impact of metabolic syndrome on the heart
H. Lamb, Leiden/NL
Comprehensive CT/MRI evaluation of vasculitis
J. H. Choe, Seoul/KR
The heart in auto-immune and connective tissue diseases
A. Kurata, Toon/JP
Update on MR/CT imaging of amyloidosis
D. Beitzke, Vienna/AT
The great mimicker: Sarcoidosis
M. Hol, Utrecht/NL
Q&A
 
10:35-11:05 Break
 
13:55-15:25
The case I learnt most from
Moderators: A. Luca, Bukarest/RO | J. Niemierko, Gdansk/PL
Beyond the obvious: Concomitant pathologies in cardiac MRI
V. Mergen, Zurich
The case that taught me to keep asking
M. Halfmann, Mainz/DE
A diagnostic challenge in a pregnant woman: The role of time in diagnosis
S. Seitun, Genoa/IT
When suspected myocarditis took a completely different turn
A. Isaak, Bonn/DE
Not every intracardiac mass is what it seems
A. Varga-Szemes, Charleston/US
Recurrent embolic events in a patient with an atypical left atrial mass
A. Bartoli, Marseille/FR
Not just an athlete’s heart: The diagnostic value of clinical and imaging follow-up
C. Lisi, Milan/IT
Expect the unexpected: A pediatric case study
R. Takx, Amsterdam/NL